The cerebrospinal fluid management landscape is evolving steadily, supported by the growing burden of neurological disorders and increasing reliance on advanced treatment technologies. The industry was valued at US$ 1,911.37 million in 2022 and is projected to reach US$ 2,892.54 million by 2030, registering a CAGR of 5.3% during the forecast period. Rising awareness, improved...